This study uses US commercial health plan insurance data to characterize coverage for biosimilar drugs compared with reference products.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237961 | PMC |
| http://dx.doi.org/10.1001/jama.2020.2229 | DOI Listing |
Publication Analysis
Top Keywords
reference products
8
commercial health
8
coverage biosimilars
4
biosimilars reference
4
products commercial
4
health plans
4
plans study
4
study commercial
4
health plan
4
plan insurance
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!